Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 18, 2021
- Accepted September 7, 2021
- Published online September 24, 2021.
Article Versions
- You are currently viewing a previous version of this article (September 24, 2021 - 06:21).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Eric D. Bateman1⇑,
- David B. Price2,3,
- Hao-Chien Wang4,
- Adel Khattab5,
- Patricia Schonffeldt6,
- Angelina Catanzariti7,
- Ralf J. P. van der Valk8 and
- Maarten J.H.I. Beekman9
- 1Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa
- 2Observational and Pragmatic Research Institute, Singapore
- 3Division of Applied Sciences, Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK
- 4Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- 5Chest Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- 6Especialista Medicina Interna y Enfermedades Respiratorias, Instituto Nacional del Tórax ITMS Telemedicina de Chile, Santiago, Chile
- 7Medical Manager, AstraZeneca, Sydney, Australia
- 8AstraZeneca, Cambridge, UK
- 9AstraZeneca, The Hague, The Netherlands
- Eric Bateman (Eric.Bateman{at}uct.ac.za)
Funding
AstraZeneca
Article usage
Altmetrics
Vol 62 Issue 5
Table of Contents
Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
